This Article Figures Only Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (18) Citing Articles via Google Scholar Google Scholar Articles by Levitzky, Y. S. Articles by Fox, C. S. Search for Related Content PubMed PubMed Citation Articles by Levitzky, Y. S. Articles by Fox, C. S. Related Collections Related Article

CLINICAL RESEARCH: CORONARY HEART DISEASE

Impact of Impaired Fasting Glucose on Cardiovascular Disease

The Framingham Heart Study

Yamini S. Levitzky, MD^_*, Michael J. Pencina, PhD^_*,, Ralph B. D’Agostino, PhD^_*,, James B. Meigs, MD, MPH^,1, Joanne M. Murabito, MD, ScM^_*,_**, Ramachandran S. Vasan, MD^_*,||,#,2 and Caroline S. Fox, MD, MPH^_*,,,_*

^_* National Heart, Lung, and Blood Institute’s Framingham Heart Study, Framingham, Massachusetts
National Heart, Lung, and Blood Institute, Bethesda, Maryland
Statistics and Consulting Unit, Department of Mathematics, Boston University, Boston, Massachusetts
Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts
^|| Cardiology Section, Boston University School of Medicine, Boston, Massachusetts
^# Department of Preventive Medicine and Epidemiology, Boston University School of Medicine, Boston, Massachusetts
^_** Section of General Internal Medicine, Department of Medicine, Boston Medical Center, Boston, Massachusetts
Department of Endocrinology, Metabolism, and Diabetes, Brigham and Women’s Hospital and Harvard Medical School, Boston, Massachusetts.

Manuscript received May 24, 2007; revised manuscript received September 12, 2007, accepted September 17, 2007.

^_* Reprint requests and correspondence: Dr. Caroline S. Fox, Framingham Heart Study, 73 Mount Wayte Avenue, Suite No. 2, Framingham, Massachusetts 01702-5827. (Email: foxca{at}nhlbi.nih.gov).

Objectives: We sought to determine whether impaired fasting glucose (IFG) predicts cardiovascular disease (CVD) events.

Background: It is unclear which glucose threshold should define prediabetes. We compared the 1997 and 2003 American Diabetes Association (ADA) definitions of IFG to predict CVD.

Methods: Framingham offspring participants free of CVD, categorized by the 1997 ADA IFG definition (fasting plasma glucose 110 to 125 mg/dl; 6.1 to 6.9 mmol/l) or the 2003 definition (100 to 125 mg/dl; 5.6 to 6.9 mmol/l), were followed from 1983 to 2004. Pooled logistic regression was used to calculate multivariable-adjusted odds ratios (ORs) for incident coronary heart disease (CHD; 291 events) or CVD (423 events).

Results: Four-year CHD event rates among women were 1.3% (100 to 109 mg/dl), 2.3% (110 to 125 mg/dl), and 2.9% (diabetes); whereas corresponding rates in men were 2.9%, 3.0%, and 8.7%. For the 2003 IFG definition, the OR for CHD among women was 1.7 (95% confidence interval [CI] 1.0 to 3.0, p = 0.048), whereas for the 1997 IFG definition, the OR for CHD in women was 2.2 (95% CI 1.1 to 4.4, p = 0.02), which was almost as high as for women with diabetes (OR 2.5, 95% CI 1.2 to 5.2, p = 0.01). For CVD, only the 1997 IFG definition yielded significantly greater odds of CVD in women (OR 2.1, 95% CI 1.2 to 3.6, p = 0.01). Men were not at increased odds of developing CVD or CHD by either definition.

Conclusions: In women, both IFG definitions were associated with increased CHD risk, whereas neither IFG definition identified men at increased short-term risk for CHD or CVD. The finding that women with FPG 110 to 125 mg/dl had similar CHD risk compared with women with diabetes suggests that CHD risk in women may be elevated at a lower glucose level than for men.

Abbreviations and Acronyms   ADA = American Diabetes Association   BMI = body mass index   CHD = coronary heart disease   CI = confidence interval   CVD = cardiovascular disease   FPG = fasting plasma glucose   IFG = impaired fasting glucose   IGT = impaired glucose tolerance   OR = odds ratio   TIA = transient ischemic attack

Related Article

Inside This Issue of JACC
J. Am. Coll. Cardiol. 2008 51: A37-A38. [Full Text] [PDF]

This article has been cited by other articles:

				S. Chatterjee and S. Maitra Impaired Fasting Glucose and the Risk of Incident Diabetes Mellitus and Cardiovascular Events J. Am. Coll. Cardiol., December 6, 2011; 58(24): 2546 - 2547. [Full Text] [PDF]

				M. Bombelli, R. Facchetti, R. Sega, S. Carugo, D. Fodri, G. Brambilla, C. Giannattasio, G. Grassi, and G. Mancia Impact of Body Mass Index and Waist Circumference on the Long-Term Risk of Diabetes Mellitus, Hypertension, and Cardiac Organ Damage Hypertension, December 1, 2011; 58(6): 1029 - 1035. [Abstract] [Full Text] [PDF]

				H. Wang, N. M. Shara, E. T. Lee, R. Devereux, D. Calhoun, G. de Simone, J. G. Umans, and B. V. Howard Hemoglobin A1c, Fasting Glucose, and Cardiovascular Risk in a Population With High Prevalence of Diabetes: The Strong Heart Study Diabetes Care, September 1, 2011; 34(9): 1952 - 1958. [Abstract] [Full Text] [PDF]

				J. Yeboah, A. G. Bertoni, D. M. Herrington, W. S. Post, and G. L. Burke Impaired Fasting Glucose and the Risk of Incident Diabetes Mellitus and Cardiovascular Events in an Adult Population: MESA (Multi-Ethnic Study of Atherosclerosis) J. Am. Coll. Cardiol., July 5, 2011; 58(2): 140 - 146. [Abstract] [Full Text] [PDF]

				N. Mustafa, N. A. Kamarudin, A. A. Ismail, A. S. Khir, I. S. Ismail, K. I. Musa, K. A. Kadir, N. A. Yaacob, O. Ali, S. H. M. Isa, et al. Prevalence of Abnormal Glucose Tolerance and Risk Factors in Urban and Rural Malaysia Diabetes Care, June 1, 2011; 34(6): 1362 - 1364. [Abstract] [Full Text] [PDF]

				B. I. Frohnert, K. L. Ode, A. Moran, B. M. Nathan, T. Laguna, B. Holme, and W. Thomas Impaired Fasting Glucose in Cystic Fibrosis Diabetes Care, December 1, 2010; 33(12): 2660 - 2664. [Abstract] [Full Text] [PDF]

				D. M. Mann, A. P. Carson, D. Shimbo, V. Fonseca, C. S. Fox, and P. Muntner Impact of A1C Screening Criterion on the Diagnosis of Pre-Diabetes Among U.S. Adults Diabetes Care, October 1, 2010; 33(10): 2190 - 2195. [Abstract] [Full Text] [PDF]

				J. B. Meigs Epidemiology of Type 2 Diabetes and Cardiovascular Disease: Translation From Population to Prevention: The Kelly West Award Lecture 2009 Diabetes Care, August 1, 2010; 33(8): 1865 - 1871. [Abstract] [Full Text] [PDF]

				S. K. PENN, A. H. KAO, L. L. SCHOTT, J. R. ELLIOTT, F. G. S. TOLEDO, L. KULLER, S. MANZI, and M. C. M. WASKO Hydroxychloroquine and Glycemia in Women with Rheumatoid Arthritis and Systemic Lupus Erythematosus J Rheumatol, June 1, 2010; 37(6): 1136 - 1142. [Abstract] [Full Text] [PDF]

				D. Preiss, P. Welsh, H. M. Murray, J. Shepherd, C. Packard, P. Macfarlane, S. Cobbe, I. Ford, and N. Sattar Fasting plasma glucose in non-diabetic participants and the risk for incident cardiovascular events, diabetes, and mortality: results from WOSCOPS 15-year follow-up Eur. Heart J., May 2, 2010; 31(10): 1230 - 1236. [Abstract] [Full Text] [PDF]

				E. S. Ford, G. Zhao, and C. Li Pre-Diabetes and the Risk for Cardiovascular Disease: A Systematic Review of the Evidence J. Am. Coll. Cardiol., March 30, 2010; 55(13): 1310 - 1317. [Abstract] [Full Text] [PDF]

				S. Nandish, J. Wyatt, N. Thukral, and R. J. Chilton Evaluating the prevalence and progression of diabetes J Am Osteopath Assoc, March 1, 2010; 110(3_suppl_3): eS3 - eS5. [Full Text] [PDF]

				Y. Doi, T. Ninomiya, J. Hata, M. Fukuhara, K. Yonemoto, M. Iwase, M. Iida, and Y. Kiyohara Impact of Glucose Tolerance Status on Development of Ischemic Stroke and Coronary Heart Disease in a General Japanese Population: The Hisayama Study Stroke, February 1, 2010; 41(2): 203 - 209. [Abstract] [Full Text] [PDF]

				M. J. McNeely, R. L. McClelland, D. E. Bild, D. R. Jacobs Jr, R. P. Tracy, M. Cushman, D. C. Goff Jr, B. C. Astor, S. Shea, and D. S. Siscovick The Association Between A1C and Subclinical Cardiovascular Disease: The Multi-Ethnic Study of Atherosclerosis Diabetes Care, September 1, 2009; 32(9): 1727 - 1733. [Abstract] [Full Text] [PDF]

				A. Grover, K. Gorman, T. M. Dall, R. Jonas, B. Lytle, R. Shemin, D. Wood, and I. Kron Shortage of Cardiothoracic Surgeons Is Likely by 2020 Circulation, August 11, 2009; 120(6): 488 - 494. [Abstract] [Full Text] [PDF]

				R. M. Cooper-DeHoff, M. A. Pacanowski, and C. J. Pepine Cardiovascular Therapies and Associated Glucose Homeostasis: Implications Across the Dysglycemia Continuum J. Am. Coll. Cardiol., February 3, 2009; 53(5_Suppl_S): S28 - S34. [Abstract] [Full Text] [PDF]

				D.-c. Lee, X. Sui, T. S. Church, I.-M. Lee, and S. N. Blair Associations of Cardiorespiratory Fitness and Obesity With Risks of Impaired Fasting Glucose and Type 2 Diabetes in Men Diabetes Care, February 1, 2009; 32(2): 257 - 262. [Abstract] [Full Text] [PDF]

				C. W.C. Kendall, A. Esfahani, A. J. Hoffman, A. Evans, L. M. Sanders, A. R. Josse, E. Vidgen, and S. M. Potter Effect of Novel Maize-based Dietary Fibers on Postprandial Glycemia and Insulinemia J. Am. Coll. Nutr., December 1, 2008; 27(6): 711 - 718. [Abstract] [Full Text] [PDF]